SWM
NUVB icon

SHP Wealth Management’s Nuvation Bio NUVB Stock Holding History

SHP Wealth Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.58K Hold
2,000
– – ﹤0.01% 943
2025
Q4 		$17.9K Buy
+2,000
New +$12.4K ﹤0.01% 704

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SHP Wealth Management's NUVB Position: Q1 2026 in Review

SHP Wealth Management held its Nuvation Bio (NUVB) position steady in Q1 2026 at 2,000 shares worth $8.58K. The position accounts for ﹤0.01% of the portfolio, ranked #943.

SHP Wealth Management first reported a position in NUVB in Q4 2025 and has held it in 2 quarters since. The position peaked at $17.9K in Q4 2025. 233 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • SHP Wealth Management held 2,000 shares of Nuvation Bio worth $8.58K as of Q1 2026.
  • SHP Wealth Management left its Nuvation Bio share count unchanged in Q1 2026.
  • Nuvation Bio made up ﹤0.01% of SHP Wealth Management's portfolio in Q1 2026, its #943 holding.
  • SHP Wealth Management first reported a position in Nuvation Bio in Q4 2025 and has held it in 2 quarters since.
  • SHP Wealth Management's Nuvation Bio position peaked at $17.9K in Q4 2025.
  • 233 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on SHP Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.